Protagonist Therapeutics, Inc. (PTGX)
99.19
-2.82
(-2.76%)
USD |
NASDAQ |
May 22, 16:00
99.11
-0.08
(-0.08%)
After-Hours: 20:00
Protagonist Therapeutics EPS Diluted (Quarterly) : 0.0537 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Johnson & Johnson | 2.141 |
| AbbVie, Inc. | 0.3861 |
| Insmed, Inc. | -0.7591 |
| Madrigal Pharmaceuticals, Inc. | -3.251 |
| PTC Therapeutics, Inc. | -0.034 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 3.783M |
| Revenue (Quarterly) | 56.37M |
| Total Expenses (Quarterly) | 52.58M |
| Enterprise Value | 5.841B |
| Gross Profit Margin (Quarterly) | 99.28% |
| Profit Margin (Quarterly) | 6.71% |
| Earnings Yield | -1.82% |
| Normalized Earnings Yield | -1.818 |